| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/03/2009 | US7498342 Compounds modulating c-kit activity |
| 03/03/2009 | US7498333 treatment or prophylaxis of cancer; inhibit the microtubule motor protein HsEg5; N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydroisothiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide |
| 03/03/2009 | US7498326 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 03/03/2009 | US7498325 Modified amino acids, pharmaceuticals containing these compounds and method for their production |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | US20090054644 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054422 New Oxabispidine Compounds For The Treatment Of Cardiac Arrhythmias |
| 02/26/2009 | US20090054418 8-(2-{cis-4-[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-hydroxycyclohexyl}ethyl)-2H-chromen-2-one; may be formulated for administration in any convenient way; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 02/26/2009 | US20090054399 Hiv integrase inhibitors |
| 02/26/2009 | US20090053307 Immediate-release therapeutic systems for improved oral absorption of 7-[(e)]-t-buty-loxyminomethyl] camptothecin |
| 02/26/2009 | CA2701606A1 Antifungal agents |
| 02/25/2009 | EP2027131A1 39-desmethoxy-39-methyl derivatives of rapamycin. |
| 02/25/2009 | CN101374847A Process for the preparation of rapamycin derivatives |
| 02/24/2009 | US7495101 Reacting 4-methyl-5-alkoxy-oxazole with substituted dihydro-(1,3)-dioxepin compound, in absence of solvent and catalyst to give product mixture consisting of Diels-Alder adducts; distillation; hydrolysis; deblocking, deprotecting; deacylation |
| 02/24/2009 | US7495096 Processes for the production of chinazoline alkaloids |
| 02/24/2009 | US7495009 Imidazopyridine derivatives as melancortin receptor agonists |
| 02/24/2009 | US7494996 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants |
| 02/24/2009 | US7494992 Antiparasitic terpene alkaloids |
| 02/24/2009 | US7494991 For microbial infections specially Gram-positive bacterial infection; atherosclerosis-associated disease |
| 02/19/2009 | WO2009021990A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | WO2007095389A3 Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs |
| 02/19/2009 | US20090048286 Inhibitors of Protein Tyrosine Phosphatase 1B |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048247 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type - iv |
| 02/19/2009 | US20090048242 (1,10b-dihydro-2-(aminoalkyl-phenyl)-5h-pyrazolo[1,5 c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors |
| 02/19/2009 | US20090048241 such as 4-(5,6-Dihydro-8H-imidazo[5,1-c][1,4]oxazin-8-yl)benzonitrile, used for the treatment of estrogen-dependent breast cancer and urogenital disorders |
| 02/19/2009 | US20090048213 Prodrug of cinnamide compound |
| 02/19/2009 | US20090047692 Optically-detectable enzyme substrates and their method of use |
| 02/19/2009 | US20090047324 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | US20090047323 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | CA2695251A1 Fused imidazoles for cancer treatment |
| 02/18/2009 | EP2024373A1 Tricyclic oxazepines as in vivo imaging compounds |
| 02/18/2009 | EP2024365A2 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 02/18/2009 | EP1675852B1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 02/18/2009 | EP1575952B1 Synthesis of heteroaryl acetamides |
| 02/18/2009 | CN101367824A Preparation method for compound containing 1,2,3,11b-tetrahydric-[1,2] azine-[3,2-a] isoquinoline framework |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491819 N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor |
| 02/17/2009 | US7491716 Glycogen synthase kinase-3 inhibitors such as [1-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-6,7-dihydro-6H-[1,4]diazepino[6,7,1-hi]indol-6-yl]-[morpholin-4-yl]methylenecyanamide, used for treating diabetes, Alzheimer's disease and for stimulating bone deposition in mammals |
| 02/17/2009 | US7491714 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2384440C Method for separating lactone-containing high-molecular weight compounds |
| 02/17/2009 | CA2355283C Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/17/2009 | CA2316474C Stabilizer mixtures |
| 02/12/2009 | WO2009020580A1 Gamma secretase modulators |
| 02/12/2009 | US20090043116 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 02/12/2009 | US20090042895 Antidepressant Piperidine Derivatives of Heterocycle-Fused Benzodioxans |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042856 Pyridazinone derivatives used for the treatment of pain |
| 02/12/2009 | CA2695543A1 Gamma secretase modulators |
| 02/11/2009 | EP1605938B1 Antibacterial derivatives of napthydrin and quinoline |
| 02/11/2009 | CN101365704A Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib |
| 02/11/2009 | CN101365703A Heteroalkyl linked pyrimidine derivatives |
| 02/10/2009 | US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors |
| 02/10/2009 | US7488736 serotonin receptor agonist and antagonist; antidepressant, anxoilytic agent, neurodegenerative diseases; neurodegenerative disease, cognition disorders, irritable bowel syndrome, nausea; 6,7-Dihydro-4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno[2,3-b]pyridine-5-carboxamid potassium salt |
| 02/10/2009 | US7488726 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, a 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-benzoxazinorifamycin |
| 02/05/2009 | WO2009018551A2 Therapeutic compounds |
| 02/05/2009 | WO2009018549A1 Therapeutic compounds |
| 02/05/2009 | WO2009016462A2 Substituted bicyclolactam compounds |
| 02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | WO2009016132A1 Pyrrolopyrimidines |
| 02/05/2009 | WO2009016085A1 Spiro compounds useful as antagonists of the h1 receptor |
| 02/05/2009 | US20090036675 New process for production of oxabispidines |
| 02/05/2009 | US20090036673 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes |
| 02/05/2009 | US20090035809 Modified Carbocyanine Dyes and Their Conjugates |
| 02/05/2009 | DE10026131B4 Unsymmetrische Dioxazinverbindung, dichromatischer Farbstoff, Flüssigkristallzusammensetzung und Flüssigkristallanzeigeelement Unbalanced dioxazine, dichroic dye liquid crystal composition and liquid crystal display element |
| 02/05/2009 | CA2693715A1 Pyrrolopyrimidines |
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2009 | CN101360752A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 02/04/2009 | CN101360751A Oxygen linked pyrimidine derivatives |
| 02/04/2009 | CN100457731C Benzamide modulators of metabotropic glutamate receptors |
| 02/03/2009 | US7485722 E.g., 3-(2'-Morpholin-4-ylmethyl-biphenyl-4-ylmethyl)-1-oxa-3-aza-spiro[4.5]decan-2-one; acute and chronic neurological and psychiatric disorders and chronic and acute pain disorders; Alzheimer's disease; schizophrenia; antidepressants; bipolar disorders; antiischemic agents; cardiotonic agents |
| 02/03/2009 | US7485706 Has a domain that preferentially binds to aggregations comprising at least two monomeric proteins linked to a second domain that recruits the aggregation modifying protein; neurotoxicity; neurodegenerative diseases |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 01/29/2009 | WO2009013477A1 Compounds for treating duchenne muscular dystrophy |
| 01/29/2009 | WO2007114848A3 Chemical compounds |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029980 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents |
| 01/29/2009 | US20090029979 5-htx modulators |
| 01/29/2009 | US20090029978 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 01/29/2009 | US20090029965 Vasopressin V1a Antagonists |
| 01/29/2009 | US20090029426 Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
| 01/29/2009 | CA2685599A1 Compounds for treating duchenne muscular dystrophy |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | CN101356174A Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 01/27/2009 | US7482452 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
| 01/27/2009 | US7482350 4,5-disubstituted-2-aryl pyrimidines |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/22/2009 | WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | WO2009010925A2 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 01/22/2009 | WO2009010801A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 01/22/2009 | WO2009010694A2 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same |
| 01/22/2009 | WO2009010555A1 New drugs with anticholestatic activity |
| 01/22/2009 | WO2009010260A2 Condensed anthranilamide insecticides |
| 01/22/2009 | WO2008109177A3 Metalloprotease inhibitors containing a heterocyclic moiety |